Medical Supervised Duodenal-Enteral Feeding Treatment

BiomediKcal

Status: Completed

Conditions: Weight Loss; Hormone Disturbance; Obesity, Visceral; Overweight and Obesity; Feeding and Eating Disorders; Obesity; Body Fat Disorder

Treatments: Dietary Supplement: Nasogastroduodenal Protocol; Other: Control; Other: Data analysis

Study type: Interventional

Funder types: Other

Identifiers

NCT03542864

BCE26418

Details and patient eligibility

About

Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it.

Full description

Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it. The feeding is by nasogastric-duodenal tube depending on the desired fat loss and / or weight in relation to the basal metabolism. Feeding by tube of 12-29 days, continuing with personalized nutritional treatment for 2 weeks and physical activity during the protocol. Losses of weight and / or expected fat greater than 10%. The results will be compared with bariatric surgery. The main objective is to provide a tool for the obesity epidemic that can be applied worldwide by doctors without the complications of surgery and with a lower price for health systems and controlling the actions of the hormones leptin and ghrelin.

Enrollment: 31 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Desire for weight loss, desire to improve body image, voluntariness

Exclusion criteria

• esophageal alteration or swallowing, not sign the informed consent, acute active disease

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

31 participants in 3 patient groups

Nasogastroduodenal Protocol

Experimental group

Description:

Evaluation of a protocol for the treatment of excess body fat through duodenal nutrition

Treatment:

Dietary Supplement: Nasogastroduodenal Protocol

Controls

Active Comparator group

Description:

Change from Baseline Body Composition values at 1 and 3 months

Treatment:

Other: Control

Data analysis

Other group

Description:

Analysis and publication of data

Treatment:

Other: Data analysis